Arecor Therapeutics (LON:AREC) Stock Price Down 0.3% – What’s Next?

Arecor Therapeutics plc (LON:AREC) shares dropped 0.3% on Wednesday . The stock traded as low as GBX 69.66 and last traded at GBX 71.75. Approximately 38,465 shares changed hands during trading, an increase of 96% from the average daily volume of 19,647 shares. The stock had previously closed at GBX 72.

Arecor Therapeutics Price Performance

The company has a 50-day moving average of GBX 79.71 and a 200-day moving average of GBX 76.22. The company has a debt-to-equity ratio of 6.06, a quick ratio of 6.24 and a current ratio of 2.05. The stock has a market cap of £27.09 million, a price-to-earnings ratio of -3.12 and a beta of -0.18.

About Arecor Therapeutics

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio.